FDA Drug Label · 2022

MOUNJARO (tirzepatide) injection, for subcutaneous use - Prescribing Information

Eli Lilly (2022). MOUNJARO (tirzepatide) injection, for subcutaneous use - Prescribing Information. FDA Drug Label.

FDA Drug Label

Source: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d2d7da5d-ad07-4228-955f-cf7e355c8cc0

Last reviewed September 19, 2026. By the PeptIQ team.

Peptides linked in PeptIQ Wiki

Tirzepatide — community report

This page indexes a published source for discovery and cross-linking. PeptIQ reports what the literature contains and what users track — it does not interpret studies as treatment guidance.